ACS Medicinal Chemistry Letters · 2014 · 185 citations · 15 references
Life SciencesBiochemistryMedicinal ChemistryChromatin BiologyDrug DiscoveryEnzymologyChromatinEnzyme InhibitionHistone ModificationsHistone Post-translational ModificationsHistone ProteinsHistone DemethylasesHistone MethylationHistone Methylation At Lysine 9Histone Methyltransferase InhibitionHistone MethyltransferasesHistone-lysine MethylationLysine Methyltransferase ActivitySelectivity
G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.
15
Ligand efficiency indices as guideposts for drug discovery
C ABADZAPATERO · Drug Discovery Today · 2005 · 523 citations